Patents Assigned to VASCUGEN, INC.
  • ENGINEERING MESODERMAL PRECURSOR CELL COMPOSITIONS FOR THE TREATMENT OR PROPHYLAXIS OF PERFUSION DISORDERS
    Publication number: 20200281986
    Abstract: The present disclosure describes the engineering of a mesodermal precursor cell population obtained through the differentiation of induced pluripotent stem cells (iPSCs) for the cell therapy treatment of perfusion disorders. The modifications improve the survival and clonal proliferation of the mesodermal precursor cell population ex vivo and facilitate their migration to sites of ischemic injury in vivo.
    Type: Application
    Filed: September 6, 2019
    Publication date: September 10, 2020
    Applicant: VASCUGEN, INC.
    Inventor: Mervin C. Yoder